메뉴 건너뛰기




Volumn 85, Issue 12, 2011, Pages 5825-5839

Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; VIRUS ENVELOPE PROTEIN;

EID: 79958086672     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00154-11     Document Type: Article
Times cited : (94)

References (84)
  • 1
    • 0037847545 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion
    • Abrahamyan, L. G., R. M. Markosyan, J. P. Moore, F. S. Cohen, and G. B. Melikyan. 2003. Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion. J. Virol. 77:5829-5836.
    • (2003) J. Virol. , vol.77 , pp. 5829-5836
    • Abrahamyan, L.G.1    Markosyan, R.M.2    Moore, J.P.3    Cohen, F.S.4    Melikyan, G.B.5
  • 2
    • 0023678874 scopus 로고
    • Expression of membrane-associated and secreted variants of gp160 of human immunodeficiency virus type 1 in vitro and in continuous cell lines
    • Berman, P. W., W. M. Nunes, and O. K. Haffar. 1988. Expression of membrane-associated and secreted variants of gp160 of human immunodeficiency virus type 1 in vitro and in continuous cell lines. J. Virol. 62:3135-3142.
    • (1988) J. Virol. , vol.62 , pp. 3135-3142
    • Berman, P.W.1    Nunes, W.M.2    Haffar, O.K.3
  • 3
    • 78651243915 scopus 로고    scopus 로고
    • Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum
    • Bhattacharyya, S., and T. J. Hope. 2011. Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum. Virol. J. 8:11.
    • (2011) Virol. J. , vol.8 , pp. 11
    • Bhattacharyya, S.1    Hope, T.J.2
  • 4
    • 77952001983 scopus 로고    scopus 로고
    • Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization
    • Binley, J., et al. 2010. Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization. J. Virol. 84:5637-5655.
    • (2010) J. Virol. , vol.84 , pp. 5637-5655
    • Binley, J.1
  • 5
    • 0038076112 scopus 로고    scopus 로고
    • Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions
    • Binley, J. M., et al. 2003. Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions. J. Virol. 77:5678-5684.
    • (2003) J. Virol. , vol.77 , pp. 5678-5684
    • Binley, J.M.1
  • 6
    • 56449131391 scopus 로고    scopus 로고
    • Profiling the specificity of neutralizing antibodies in a large panel of HIV-1 plasmas from subtype B and C chronic infections
    • Binley, J. M., et al. 2008. Profiling the specificity of neutralizing antibodies in a large panel of HIV-1 plasmas from subtype B and C chronic infections. J. Virol. 82:11651-11668.
    • (2008) J. Virol. , vol.82 , pp. 11651-11668
    • Binley, J.M.1
  • 7
    • 0033985999 scopus 로고    scopus 로고
    • A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure
    • Binley, J. M., et al. 2000. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. J. Virol. 74:627-643.
    • (2000) J. Virol. , vol.74 , pp. 627-643
    • Binley, J.M.1
  • 8
    • 0036184790 scopus 로고    scopus 로고
    • Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins
    • Binley, J. M., et al. 2002. Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 76:2606- 2616.
    • (2002) J. Virol. , vol.76 , pp. 2606-2616
    • Binley, J.M.1
  • 9
    • 8644251891 scopus 로고    scopus 로고
    • Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
    • Binley, J. M., et al. 2004. Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J. Virol. 78:13232-13252.
    • (2004) J. Virol. , vol.78 , pp. 13232-13252
    • Binley, J.M.1
  • 10
    • 0025319347 scopus 로고
    • Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site
    • Bosch, V., and M. Pawlita. 1990. Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site. J. Virol. 64:2337-2344.
    • (1990) J. Virol. , vol.64 , pp. 2337-2344
    • Bosch, V.1    Pawlita, M.2
  • 11
    • 0027985431 scopus 로고
    • Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
    • Burton, D. R., et al. 1994. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266:1024- 1027.
    • (1994) Science , vol.266 , pp. 1024-1027
    • Burton, D.R.1
  • 12
    • 12444291017 scopus 로고    scopus 로고
    • Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
    • Calarese, D. A., et al. 2003. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300:2065-2071.
    • (2003) Science , vol.300 , pp. 2065-2071
    • Calarese, D.A.1
  • 13
    • 0036317971 scopus 로고    scopus 로고
    • Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface
    • Center, R. J., et al. 2002. Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface. J. Virol. 76:7863- 7867.
    • (2002) J. Virol. , vol.76 , pp. 7863-7867
    • Center, R.J.1
  • 14
    • 20244369446 scopus 로고    scopus 로고
    • Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses
    • Chen, X., et al. 2005. Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses. J. Virol. 79:5537-5547.
    • (2005) J. Virol. , vol.79 , pp. 5537-5547
    • Chen, X.1
  • 15
    • 0036091692 scopus 로고    scopus 로고
    • Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus
    • Chertova, E., et al. 2002. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus. J. Virol. 76:5315-5325.
    • (2002) J. Virol. , vol.76 , pp. 5315-5325
    • Chertova, E.1
  • 16
    • 45049083040 scopus 로고    scopus 로고
    • Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization
    • Crooks, E. T., et al. 2008. Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization. Virology 377:364-378.
    • (2008) Virology , vol.377 , pp. 364-378
    • Crooks, E.T.1
  • 17
    • 34548577658 scopus 로고    scopus 로고
    • A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120
    • Crooks, E. T., et al. 2007. A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120. Virology 366:245-262.
    • (2007) Virology , vol.366 , pp. 245-262
    • Crooks, E.T.1
  • 18
    • 33646720281 scopus 로고    scopus 로고
    • Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization
    • Crooks, E. T., et al. 2005. Characterizing anti-HIV monoclonal antibodies and immune sera by defining the mechanism of neutralization. Hum. Antibodies 14:101-113.
    • (2005) Hum. Antibodies , vol.14 , pp. 101-113
    • Crooks, E.T.1
  • 19
    • 7244232761 scopus 로고    scopus 로고
    • Characterization of glycopeptides from HIV-I(SF2) gp120 by liquid chromatography mass spectrometry
    • Cutalo, J. M., L. J. Deterding, and K. B. Tomer. 2004. Characterization of glycopeptides from HIV-I(SF2) gp120 by liquid chromatography mass spectrometry. J. Am. Soc. Mass Spectrom. 15:1545-1555.
    • (2004) J. Am. Soc. Mass Spectrom. , vol.15 , pp. 1545-1555
    • Cutalo, J.M.1    Deterding, L.J.2    Tomer, K.B.3
  • 20
    • 0024334165 scopus 로고
    • Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport
    • Dewar, R. L., M. B. Vasudevachari, V. Natarajan, and N. P. Salzman. 1989. Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport. J. Virol. 63:2452-2456.
    • (1989) J. Virol. , vol.63 , pp. 2452-2456
    • Dewar, R.L.1    Vasudevachari, M.B.2    Natarajan, V.3    Salzman, N.P.4
  • 21
    • 77956385205 scopus 로고    scopus 로고
    • Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens
    • Doores, K. J., et al. 2010. Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens. Proc. Natl. Acad. Sci. U. S. A. 107: 13800-13805.
    • (2010) Proc. Natl. Acad. Sci. U. S. A. , vol.107 , pp. 13800-13805
    • Doores, K.J.1
  • 22
    • 0025095635 scopus 로고
    • Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein
    • Earl, P. L., R. W. Doms, and B. Moss. 1990. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 87:648-652.
    • (1990) Proc. Natl. Acad. Sci. U. S. A. , vol.87 , pp. 648-652
    • Earl, P.L.1    Doms, R.W.2    Moss, B.3
  • 23
    • 0026029621 scopus 로고
    • Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein
    • Earl, P. L., B. Moss, and R. W. Doms. 1991. Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein. J. Virol. 65:2047-2055.
    • (1991) J. Virol. , vol.65 , pp. 2047-2055
    • Earl, P.L.1    Moss, B.2    Doms, R.W.3
  • 24
    • 77951988965 scopus 로고    scopus 로고
    • Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function
    • Eggink, D., et al. 2010. Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function. Virology 401:236-247.
    • (2010) Virology , vol.401 , pp. 236-247
    • Eggink, D.1
  • 25
    • 0026577244 scopus 로고
    • Immunological analysis of human immunodeficiency virus type 1 envelope glycoprotein proteolytic cleavage
    • Fenouillet, E., and J. C. Gluckman. 1992. Immunological analysis of human immunodeficiency virus type 1 envelope glycoprotein proteolytic cleavage. Virology 187:825-828.
    • (1992) Virology , vol.187 , pp. 825-828
    • Fenouillet, E.1    Gluckman, J.C.2
  • 26
    • 0029925311 scopus 로고    scopus 로고
    • Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines
    • Fenouillet, E., R. Miquelis, and R. Drillien. 1996. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines. Virology 218:224-231.
    • (1996) Virology , vol.218 , pp. 224-231
    • Fenouillet, E.1    Miquelis, R.2    Drillien, R.3
  • 27
    • 69549103041 scopus 로고    scopus 로고
    • Fc receptor-mediated antiviral antibodies
    • Forthal, D. N., and C. Moog. 2009. Fc receptor-mediated antiviral antibodies. Curr. Opin. HIV AIDS 4:388-393.
    • (2009) Curr. Opin. HIV AIDS , vol.4 , pp. 388-393
    • Forthal, D.N.1    Moog, C.2
  • 28
    • 0030897825 scopus 로고    scopus 로고
    • Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex
    • Fouts, T. R., J. M. Binley, A. Trkola, J. E. Robinson, and J. P. Moore. 1997. Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex. J. Virol. 71:2779- 2785.
    • (1997) J. Virol. , vol.71 , pp. 2779-2785
    • Fouts, T.R.1    Binley, J.M.2    Trkola, A.3    Robinson, J.E.4    Moore, J.P.5
  • 29
    • 29444442970 scopus 로고    scopus 로고
    • Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection
    • Frost, S. D., et al. 2005. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc. Natl. Acad. Sci. U. S. A. 102:18514-18519.
    • (2005) Proc. Natl. Acad. Sci. U. S. A. , vol.102 , pp. 18514-18519
    • Frost, S.D.1
  • 30
    • 0032763888 scopus 로고    scopus 로고
    • Evolutionary considerations in relating oligosaccharide diversity to biological function
    • Gagneux, P., and A. Varki. 1999. Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology 9:747-755.
    • (1999) Glycobiology , vol.9 , pp. 747-755
    • Gagneux, P.1    Varki, A.2
  • 31
    • 0023811767 scopus 로고
    • Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120
    • Geyer, H., C. Holschbach, G. Hunsmann, and J. Schneider. 1988. Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120. J. Biol. Chem. 263:11760-11767.
    • (1988) J. Biol. Chem. , vol.263 , pp. 11760-11767
    • Geyer, H.1    Holschbach, C.2    Hunsmann, G.3    Schneider, J.4
  • 32
    • 45549101708 scopus 로고    scopus 로고
    • Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility
    • Go, E. P., et al. 2008. Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility. J. Proteome Res. 7:1660-1674.
    • (2008) J. Proteome Res. , vol.7 , pp. 1660-1674
    • Go, E.P.1
  • 33
    • 34648816125 scopus 로고    scopus 로고
    • N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralization
    • Gray, E. S., P. L. Moore, R. A. Pantophlet, and L. Morris. 2007. N-linked glycan modifications in gp120 of human immunodeficiency virus type 1 subtype C render partial sensitivity to 2G12 antibody neutralization. J. Virol. 81:10769-10776.
    • (2007) J. Virol. , vol.81 , pp. 10769-10776
    • Gray, E.S.1    Moore, P.L.2    Pantophlet, R.A.3    Morris, L.4
  • 34
    • 27744503475 scopus 로고    scopus 로고
    • Induction of neutralizing antibodies against human immunodeficiency virus type 1 primary isolates by Gag-Env pseudovirion immunization
    • Hammonds, J., et al. 2005. Induction of neutralizing antibodies against human immunodeficiency virus type 1 primary isolates by Gag-Env pseudovirion immunization. J. Virol. 79:14804-14814.
    • (2005) J. Virol. , vol.79 , pp. 14804-14814
    • Hammonds, J.1
  • 35
    • 33746763724 scopus 로고    scopus 로고
    • Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
    • Haynes, B. F., and D. C. Montefiori. 2006. Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates. Expert Rev. Vaccines 5:347-363.
    • (2006) Expert Rev. Vaccines , vol.5 , pp. 347-363
    • Haynes, B.F.1    Montefiori, D.C.2
  • 36
    • 77954110431 scopus 로고    scopus 로고
    • Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes
    • Hioe, C. E., et al. 2010. Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes. PLoS One 5:e10254.
    • (2010) PLoS One , vol.5
    • Hioe, C.E.1
  • 37
    • 67650741139 scopus 로고    scopus 로고
    • Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1
    • Kang, Y. K., et al. 2009. Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1. Vaccine 27:5120- 5132.
    • (2009) Vaccine , vol.27 , pp. 5120-5132
    • Kang, Y.K.1
  • 38
    • 0023678264 scopus 로고
    • Improved antigenicity of the HIV env protein by cleavage site removal
    • Kieny, M. P., et al. 1988. Improved antigenicity of the HIV env protein by cleavage site removal. Protein Eng. 2:219-225.
    • (1988) Protein Eng , vol.2 , pp. 219-225
    • Kieny, M.P.1
  • 39
    • 0021891884 scopus 로고
    • Assembly of asparagine-linked oligosaccharides
    • Kornfeld, R., and S. Kornfeld. 1985. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54:631-664.
    • (1985) Annu. Rev. Biochem. , vol.54 , pp. 631-664
    • Kornfeld, R.1    Kornfeld, S.2
  • 40
    • 0033555453 scopus 로고    scopus 로고
    • Fusion-competent vaccines: broad neutralization of primary isolates of HIV
    • LaCasse, R. A., et al. 1999. Fusion-competent vaccines: broad neutralization of primary isolates of HIV. Science 283:357-362.
    • (1999) Science , vol.283 , pp. 357-362
    • LaCasse, R.A.1
  • 41
    • 0038725418 scopus 로고    scopus 로고
    • Folding of HIV-1 envelope glycoprotein involves extensive isomerization of disulfide bonds and conformation-dependent leader peptide cleavage
    • Land, A., D. Zonneveld, and I. Braakman. 2003. Folding of HIV-1 envelope glycoprotein involves extensive isomerization of disulfide bonds and conformation-dependent leader peptide cleavage. FASEB J. 17:1058-1067.
    • (2003) FASEB J , vol.17 , pp. 1058-1067
    • Land, A.1    Zonneveld, D.2    Braakman, I.3
  • 42
    • 33947712049 scopus 로고    scopus 로고
    • Combined single-clade candidate HIV-1 vaccines induce T cell responses limited by multiple forms of in vivo immune interference
    • Larke, N., et al. 2007. Combined single-clade candidate HIV-1 vaccines induce T cell responses limited by multiple forms of in vivo immune interference. Eur. J. Immunol. 37:566-577.
    • (2007) Eur. J. Immunol. , vol.37 , pp. 566-577
    • Larke, N.1
  • 43
    • 77949378988 scopus 로고    scopus 로고
    • In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1
    • Leaman, D. P., H. Kinkead, and M. B. Zwick. 2010. In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1. J. Virol. 84:3382-3395.
    • (2010) J. Virol. , vol.84 , pp. 3382-3395
    • Leaman, D.P.1    Kinkead, H.2    Zwick, M.B.3
  • 44
    • 23244434512 scopus 로고    scopus 로고
    • Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccineelicited neutralizing antibodies
    • Li, M., et al. 2005. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccineelicited neutralizing antibodies. J. Virol. 79:10108-10125.
    • (2005) J. Virol. , vol.79 , pp. 10108-10125
    • Li, M.1
  • 45
    • 33751224478 scopus 로고    scopus 로고
    • Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa
    • Li, M., et al. 2006. Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. J. Virol. 80:11776- 11790.
    • (2006) J. Virol. , vol.80 , pp. 11776-11790
    • Li, M.1
  • 46
    • 0029792920 scopus 로고    scopus 로고
    • Effects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transport
    • Li, Y., et al. 1996. Effects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transport. Proc. Natl. Acad. Sci. U. S. A. 93:9606-9611.
    • (1996) Proc. Natl. Acad. Sci. U. S. A. , vol.93 , pp. 9606-9611
    • Li, Y.1
  • 47
    • 0027535672 scopus 로고
    • Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding
    • Li, Y., L. Luo, N. Rasool, and C. Y. Kang. 1993. Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. J. Virol. 67:584-588.
    • (1993) J. Virol. , vol.67 , pp. 584-588
    • Li, Y.1    Luo, L.2    Rasool, N.3    Kang, C.Y.4
  • 48
    • 0034608884 scopus 로고    scopus 로고
    • The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding
    • Li, Y., L. Luo, D. Y. Thomas, and C. Y. Kang. 2000. The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding. Virology 272:417-428.
    • (2000) Virology , vol.272 , pp. 417-428
    • Li, Y.1    Luo, L.2    Thomas, D.Y.3    Kang, C.Y.4
  • 49
    • 1942517392 scopus 로고    scopus 로고
    • Thrombin activates envelope glycoproteins of HIV type 1 and enhances fusion
    • Ling, H., P. Xiao, O. Usami, and T. Hattori. 2004. Thrombin activates envelope glycoproteins of HIV type 1 and enhances fusion. Microbes Infect. 6:414-420.
    • (2004) Microbes Infect , vol.6 , pp. 414-420
    • Ling, H.1    Xiao, P.2    Usami, O.3    Hattori, T.4
  • 50
    • 0023921610 scopus 로고
    • Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus
    • McCune, J. M., et al. 1988. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 53:55-67.
    • (1988) Cell , vol.53 , pp. 55-67
    • McCune, J.M.1
  • 51
    • 0034469405 scopus 로고    scopus 로고
    • Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases
    • Means, R. E., and R. C. Desrosiers. 2000. Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases. J. Virol. 74:11181-11190.
    • (2000) J. Virol. , vol.74 , pp. 11181-11190
    • Means, R.E.1    Desrosiers, R.C.2
  • 52
    • 78449235077 scopus 로고    scopus 로고
    • Induction of cytopathic effects and apoptosis in Spodoptera frugiperda cells by the HIV-1 Env glycoprotein signal peptide
    • Michalski, C. J., Y. Li, and C. Y. Kang. 2010. Induction of cytopathic effects and apoptosis in Spodoptera frugiperda cells by the HIV-1 Env glycoprotein signal peptide. Virus Genes 41:341-350.
    • (2010) Virus Genes , vol.41 , pp. 341-350
    • Michalski, C.J.1    Li, Y.2    Kang, C.Y.3
  • 53
    • 0025374887 scopus 로고
    • Diversity of oligosaccharide structures on the envelope glycoprotein gp120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues
    • Mizuochi, T., et al. 1990. Diversity of oligosaccharide structures on the envelope glycoprotein gp120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues. J. Biol. Chem. 265:8519-8524.
    • (1990) J. Biol. Chem. , vol.265 , pp. 8519-8524
    • Mizuochi, T.1
  • 54
    • 0025572710 scopus 로고
    • Dissociation of gp120 from HIV-1 virions induced by soluble CD4
    • Moore, J., J. McKeating, R. Weiss, and Q. Sattentau. 1990. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250:1139-1142.
    • (1990) Science , vol.250 , pp. 1139-1142
    • Moore, J.1    McKeating, J.2    Weiss, R.3    Sattentau, Q.4
  • 55
    • 33144486096 scopus 로고    scopus 로고
    • Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1
    • Moore, P. L., et al. 2006. Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. J. Virol. 80:2515-2528.
    • (2006) J. Virol. , vol.80 , pp. 2515-2528
    • Moore, P.L.1
  • 56
    • 34247106331 scopus 로고    scopus 로고
    • An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10
    • Nelson, J. D., et al. 2007. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10. J. Virol. 81:4033-4043.
    • (2007) J. Virol. , vol.81 , pp. 4033-4043
    • Nelson, J.D.1
  • 57
    • 0031710046 scopus 로고    scopus 로고
    • Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1
    • Nyambi, P. N., et al. 1998. Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1. J. Virol. 72:9384-9391.
    • (1998) J. Virol. , vol.72 , pp. 9384-9391
    • Nyambi, P.N.1
  • 58
    • 34250027638 scopus 로고    scopus 로고
    • Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis
    • Pantophlet, R., R. O. Aguilar-Sino, T. Wrin, L. A. Cavacini, and D. R. Burton. 2007. Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis. Virology 364:441-453.
    • (2007) Virology , vol.364 , pp. 441-453
    • Pantophlet, R.1    Aguilar-Sino, R.O.2    Wrin, T.3    Cavacini, L.A.4    Burton, D.R.5
  • 59
    • 34347256384 scopus 로고    scopus 로고
    • Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets
    • Phogat, S., R. T. Wyatt, and G. B. Karlsson Hedestam. 2007. Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets. J. Intern. Med. 262:26-43.
    • (2007) J. Intern. Med. , vol.262 , pp. 26-43
    • Phogat, S.1    Wyatt, R.T.2    Karlsson Hedestam, G.B.3
  • 60
    • 0037213278 scopus 로고    scopus 로고
    • Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies
    • Poignard, P., et al. 2003. Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies. J. Virol. 77:353-365.
    • (2003) J. Virol. , vol.77 , pp. 353-365
    • Poignard, P.1
  • 61
    • 20144388317 scopus 로고    scopus 로고
    • Induction of humoral immune responses following vaccination with envelope-containing, formaldehyde-treated, thermally inactivated human immunodeficiency virus type 1
    • Poon, B., et al. 2005. Induction of humoral immune responses following vaccination with envelope-containing, formaldehyde-treated, thermally inactivated human immunodeficiency virus type 1. J. Virol. 79:4927-4935.
    • (2005) J. Virol. , vol.79 , pp. 4927-4935
    • Poon, B.1
  • 62
    • 69249216589 scopus 로고    scopus 로고
    • The infectious molecular clone and pseudotyped virus models of human immunodeficiency virus type 1 exhibit significant differences in virion composition with only moderate differences in infectivity and inhibition sensitivity
    • Provine, N. M., W. B. Puryear, X. Wu, J. Overbaugh, and N. L. Haigwood. 2009. The infectious molecular clone and pseudotyped virus models of human immunodeficiency virus type 1 exhibit significant differences in virion composition with only moderate differences in infectivity and inhibition sensitivity. J. Virol. 83:9002-9007.
    • (2009) J. Virol. , vol.83 , pp. 9002-9007
    • Provine, N.M.1    Puryear, W.B.2    Wu, X.3    Overbaugh, J.4    Haigwood, N.L.5
  • 63
    • 73349094086 scopus 로고    scopus 로고
    • Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand
    • Rerks-Ngarm, S., et al. 2009. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361:2209-2220.
    • (2009) N. Engl. J. Med. , vol.361 , pp. 2209-2220
    • Rerks-Ngarm, S.1
  • 64
    • 0036637385 scopus 로고    scopus 로고
    • The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120
    • Sanders, R. W., et al. 2002. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol. 76:7293-7305.
    • (2002) J. Virol. , vol.76 , pp. 7293-7305
    • Sanders, R.W.1
  • 65
    • 0036333661 scopus 로고    scopus 로고
    • Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1
    • Sanders, R. W., et al. 2002. Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. J. Virol. 76:8875-8889.
    • (2002) J. Virol. , vol.76 , pp. 8875-8889
    • Sanders, R.W.1
  • 66
    • 18244422922 scopus 로고    scopus 로고
    • The broadly neutralizing anti-human immuno-deficiency virus type 1 antibody 2G12 recognizes a cluster of α1→2 mannose residues on the outer face of gp120
    • Scanlan, C. N., et al. 2002. The broadly neutralizing anti-human immuno-deficiency virus type 1 antibody 2G12 recognizes a cluster of α1→2 mannose residues on the outer face of gp120. J. Virol. 76:7306-7321.
    • (2002) J. Virol. , vol.76 , pp. 7306-7321
    • Scanlan, C.N.1
  • 67
    • 34547804722 scopus 로고    scopus 로고
    • Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody
    • Scanlan, C. N., et al. 2007. Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody. J. Mol. Biol. 372:16-22.
    • (2007) J. Mol. Biol. , vol.372 , pp. 16-22
    • Scanlan, C.N.1
  • 68
    • 69549091674 scopus 로고    scopus 로고
    • Challenges for structurebased HIV vaccine design
    • Schief, W. R., Y. E. Ban, and L. Stamatatos. 2009. Challenges for structurebased HIV vaccine design. Curr. Opin. HIV AIDS 4:431-440.
    • (2009) Curr. Opin. HIV AIDS , vol.4 , pp. 431-440
    • Schief, W.R.1    Ban, Y.E.2    Stamatatos, L.3
  • 69
    • 0036315133 scopus 로고    scopus 로고
    • Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein
    • Schulke, N., et al. 2002. Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein. J. Virol. 76:7760-7776.
    • (2002) J. Virol. , vol.76 , pp. 7760-7776
    • Schulke, N.1
  • 70
    • 0020035202 scopus 로고
    • Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion
    • Skehel, J. J., et al. 1982. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc. Natl. Acad. Sci. U. S. A. 79:968-972.
    • (1982) Proc. Natl. Acad. Sci. U. S. A. , vol.79 , pp. 968-972
    • Skehel, J.J.1
  • 71
    • 0025266354 scopus 로고
    • Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex
    • Stein, B. S., and E. G. Engleman. 1990. Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex. J. Biol. Chem. 265:2640-2649.
    • (1990) J. Biol. Chem. , vol.265 , pp. 2640-2649
    • Stein, B.S.1    Engleman, E.G.2
  • 72
    • 0036791359 scopus 로고    scopus 로고
    • Furin at the cutting edge: from protein traffic to embryogenesis and disease
    • Thomas, G. 2002. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat. Rev. Mol. Cell Biol. 3:753-766.
    • (2002) Nat. Rev. Mol. Cell Biol. , vol.3 , pp. 753-766
    • Thomas, G.1
  • 73
    • 55549118890 scopus 로고    scopus 로고
    • Deceptive imprinting and immune refocusing in vaccine design
    • Tobin, G. J., et al. 2008. Deceptive imprinting and immune refocusing in vaccine design. Vaccine 26:6189-6199.
    • (2008) Vaccine , vol.26 , pp. 6189-6199
    • Tobin, G.J.1
  • 74
    • 57349127300 scopus 로고    scopus 로고
    • Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia
    • Tomaras, G. D., et al. 2008. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J. Virol. 82:12449-12463.
    • (2008) J. Virol. , vol.82 , pp. 12449-12463
    • Tomaras, G.D.1
  • 75
    • 9044241681 scopus 로고    scopus 로고
    • Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
    • Trkola, A., et al. 1996. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70:1100-1108.
    • (1996) J. Virol. , vol.70 , pp. 1100-1108
    • Trkola, A.1
  • 76
    • 34250904229 scopus 로고    scopus 로고
    • The nature and consequences of intra- and inter-vaccine interference
    • Vidor, E. 2007. The nature and consequences of intra- and inter-vaccine interference. J. Comp. Pathol. 137(Suppl. 1):S62-S66.
    • (2007) J. Comp. Pathol. , vol.137 , Issue.SUPPL. 1
    • Vidor, E.1
  • 77
    • 0032853685 scopus 로고    scopus 로고
    • Immunogenicity of full-length and truncated SIV envelope proteins
    • Vzorov, A. N., D. Lea-Fox, and R. W. Compans. 1999. Immunogenicity of full-length and truncated SIV envelope proteins. Viral Immunol. 12:205- 215.
    • (1999) Viral Immunol , vol.12 , pp. 205-215
    • Vzorov, A.N.1    Lea-Fox, D.2    Compans, R.W.3
  • 78
    • 77953543379 scopus 로고    scopus 로고
    • Rational antibody-based HIV-1 vaccine design: current approaches and future directions
    • Walker, L. M., and D. R. Burton. 2010. Rational antibody-based HIV-1 vaccine design: current approaches and future directions. Curr. Opin. Immunol. 22:358-366.
    • (2010) Curr. Opin. Immunol. , vol.22 , pp. 358-366
    • Walker, L.M.1    Burton, D.R.2
  • 79
    • 78349278899 scopus 로고    scopus 로고
    • The nature and combination of subunits used in epitope-based Schistosoma japonicum vaccine formulations affect their efficacy
    • Wang, X., et al. 2010. The nature and combination of subunits used in epitope-based Schistosoma japonicum vaccine formulations affect their efficacy. Parasit. Vectors 3:109.
    • (2010) Parasit. Vectors , vol.3 , pp. 109
    • Wang, X.1
  • 80
    • 0010296944 scopus 로고
    • Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160
    • Willey, R. L., J. S. Bonifacino, B. J. Potts, M. A. Martin, and R. D. Klausner. 1988. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160. Proc. Natl. Acad. Sci. U. S. A. 85:9580-9584.
    • (1988) Proc. Natl. Acad. Sci. U. S. A. , vol.85 , pp. 9580-9584
    • Willey, R.L.1    Bonifacino, J.S.2    Potts, B.J.3    Martin, M.A.4    Klausner, R.D.5
  • 81
    • 0025813326 scopus 로고
    • Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing
    • Willey, R. L., T. Klimkait, D. M. Frucht, J. S. Bonifacino, and M. A. Martin. 1991. Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing. Virology 184:319-329.
    • (1991) Virology , vol.184 , pp. 319-329
    • Willey, R.L.1    Klimkait, T.2    Frucht, D.M.3    Bonifacino, J.S.4    Martin, M.A.5
  • 82
    • 77954920017 scopus 로고    scopus 로고
    • Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1
    • Wu, X., et al. 2010. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329:856-861.
    • (2010) Science , vol.329 , pp. 856-861
    • Wu, X.1
  • 83
    • 0036436313 scopus 로고    scopus 로고
    • Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies
    • Xiang, S. H., N. Doka, R. K. Choudhary, J. Sodroski, and J. E. Robinson. 2002. Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies. AIDS Res. Hum. Retroviruses 18:1207-1217.
    • (2002) AIDS Res. Hum. Retroviruses , vol.18 , pp. 1207-1217
    • Xiang, S.H.1    Doka, N.2    Choudhary, R.K.3    Sodroski, J.4    Robinson, J.E.5
  • 84
    • 0034687168 scopus 로고    scopus 로고
    • Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells
    • Zhu, X., C. Borchers, R. J. Bienstock, and K. B. Tomer. 2000. Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells. Biochemistry 39:11194-11204.
    • (2000) Biochemistry , vol.39 , pp. 11194-11204
    • Zhu, X.1    Borchers, C.2    Bienstock, R.J.3    Tomer, K.B.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.